The German Research Foundation (Deutsche Forschungsgemeinschaft/DFG) has approved 11 million Euro for the next four years for establishing a CRC on selective autophagy under the lead of Goethe University.
The German Research Foundation (Deutsche Forschungsgemeinschaft/DFG) has approved 11 million Euro for the next four years for establishing a CRC on selective autophagy under the lead of Goethe University. Autophagy literally means "self-eating" and refers to a sophisticated system in which cellular waste is specifically detected and removed.
It contributes to regular cell renewal, secures quality control and protects against diseases. Defects in this pathway can promote cancer development and neurodegenerative diseases like Parkinson, and contribute to infectious diseases and inflammatory reactions. The objective of the CRC is a better understanding of autophagy at the molecular and cellular level. In future, the researchers hope to be able to specifically target autophagy for improving the therapy of diverse diseases.
Professor Birgitta Wolff, President of the University, congratulated the researchers: “Well done to Ivan Dikic and his team for achieving this important milestone. The research planned within the CRC forms a promising basis for the development of new and more effective therapies. We are particularly pleased that we will be joining forces with Mainz University, the Institute of Molecular Biology in Mainz and the Georg-Speyer-Haus in the CRC – a further sign of the vitality of our regional partnerships.”
Autophagy is conserved from simple organisms such as yeast up to complex ones like humans. Typical targets for autophagy are harmful or superfluous proteins - it degrades for example aggregated proteins, which can otherwise lead to severe damage and cell death, as observed in numerous neurodegenerative diseases. Even entire cell organelles and invading pathogens such as bacteria or viruses can be eliminated via this pathway. The building blocks generated through this degradation process are recycled, which is why autophagy also functions as a survival strategy in times of low energy supply.
Autophagy is a highly complex and precisely regulated process which requires a concerted action by numerous players: The target substrate needs to be specifically recognized and surrounded by membranes to form what is known as the autophagosome. Autophagosomes fuse with lysosomes, which are cell organelles filled with digestive enzymes, finally enabling the breakdown of all cargo into the individual building blocks.
“The enormous significance of autophagy for the pathophysiology of diseases has only been recognized in the past decade. As a result, research activity in this field has increased rapidly”, explains Professor Ivan Dikic, CRC Speaker and Director of the Institute of Biochemistry II at Goethe University. “By strategic recruitments over the past five years, we have succeeded in developing Frankfurt into a centre for autophagy research. Now we are in a position to address many of the unanswered questions: What triggers autophagy? How does the cell select targets for autophagy? How does this pathway crosstalk to other cellular mechanisms and how is it involved in the pathogenesis of human diseases?”
Meanwhile it is known that the role of autophagy strongly depends on the cellular context: In healthy tissues, it prevents the emergence of cancer cells. At the same time, however, cancer cells capitalize on autophagy to overcome bottlenecks in nutrient supply, which occur as a result of rapid tumour growth. The researchers are now analysing this complex interaction. So far, little is known about the interplay of autophagy with other mechanisms, such as cellular trafficking (endocytosis), programmed cell death (apoptosis) and the ubiquitination system, which marks proteins for degradation in the proteasome.
Within the newly established CRC, researchers will study autophagy at the level of molecules, cells and model organisms. It is the first large-scale collaborative project in this field in Germany and allows scientists in Frankfurt and Mainz to position themselves in an internationally highly competitive field. A broad line-up of disciplines is needed to tackle the open questions, and therefore, within the CRC, structural biologists have teamed up with biochemists, cell biologists and clinicians. New insight into the molecular mechanisms underlying autophagy will be directly transferred to model systems for human diseases.
At Goethe University, the three faculties of Biological Sciences, Biochemistry, Chemistry and Pharmacy, and Medicine, and the cross-disciplinary Buchmann Institute for Molecular Life Sciences (BMLS) are participating in the CRC. Partners outside the University are the Institute for Pathobiochemistry at the University Medical Center of Johannes Gutenberg University Mainz (Prof. Dr. Christian Behl is Vice Speaker of the CRC), the Georg-Speyer-Haus in Frankfurt and the Institute of Molecular Biology gGmbH in Mainz.
Further information: Prof. Ivan Dikic, Institute of Biochemistry II, University Hospital Frankfurt, Tel.: (069) 6301-5652, Ivan.Dikic@biochem2.de.
Goethe University is a research-oriented university in the European financial centre Frankfurt founded in 1914 with purely private funds by liberally-oriented Frankfurt citizens. It is dedicated to research and education under the motto "Science for Society" and to this day continues to function as a "citizens’ university". Many of the early benefactors were Jewish. Over the past 100 years, Goethe University has done pioneering work in the social and sociological sciences, chemistry, quantum physics, brain research and labour law. It gained a unique level of autonomy on 1 January 2008 by returning to its historic roots as a privately funded university. Today, it is among the top ten in external funding and among the top three largest universities in Germany, with three clusters of excellence in medicine, life sciences and the humanities.
Publisher: The President of Goethe University
Editor: Dr. Anke Sauter, Science Editor, International Communication, Tel: +49(0)69 798-12477, Fax +49(0)69 798-761 12531, email@example.com
Dr. Anne Hardy | idw - Informationsdienst Wissenschaft
Förderung des Instituts für Lasertechnik und Messtechnik in Ulm mit rund 1,63 Millionen Euro
24.03.2017 | Ministerium für Wirtschaft, Arbeit und Wohnungsbau Baden-Württemberg
TU-Bauingenieure koordinieren EU-Projekt zu Recycling-Beton von über sieben Millionen Euro
24.03.2017 | Technische Universität Kaiserslautern
Wie kann man Quanteninformation zuverlässig übertragen, wenn man in der Verbindungsleitung mit störendem Rauschen zu kämpfen hat? Uni Innsbruck und TU Wien präsentieren neue Lösungen.
Wir kommunizieren heute mit Hilfe von Funksignalen, wir schicken elektrische Impulse durch lange Leitungen – doch das könnte sich bald ändern. Derzeit wird...
Das Institut für Halbleitertechnik und das Institut für Physikalische und Theoretische Chemie, beide Mitglieder des Laboratory for Emerging Nanometrology (LENA), der Technischen Universität Braunschweig, sind Partner des kürzlich gestarteten EU-Forschungsprojektes ChipScope. Ziel ist es, ein neues, extrem kleines Lichtmikroskop zu entwickeln. Damit soll das Innere lebender Zellen in Echtzeit beobachtet werden können. Sieben Institute in fünf europäischen Ländern beteiligen sich über die nächsten vier Jahre an diesem technologisch anspruchsvollen Projekt.
Die zukünftigen Einsatzmöglichkeiten des neu zu entwickelnden und nur wenige Millimeter großen Mikroskops sind äußerst vielfältig. Die Projektpartner haben...
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Ein Kristall besteht aus perfekt angeordneten Teilchen, aus einer lückenlos symmetrischen Atomstruktur – dies besagt die klassische Definition aus der Physik....
Eine internationale Forschergruppe mit dem Bayreuther Biochemiker Prof. Dr. Clemens Steegborn präsentiert in 'Science' neue, für die Biomedizin wegweisende Forschungsergebnisse zur Rolle des Moleküls NAD⁺ bei der Korrektur von Schäden am Erbgut.
Die Zellen von Menschen und Tieren können Schäden an der DNA, dem Träger der Erbinformation, bis zu einem gewissen Umfang selbst reparieren. Diese Fähigkeit...
28.03.2017 | Veranstaltungen
28.03.2017 | Veranstaltungen
27.03.2017 | Veranstaltungen